Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Apr;146(4):876–887.

Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

H Kitamura 1, Y Kameda 1, N Nakamura 1, Y Nakatani 1, Y Inayama 1, M Iida 1, K Noda 1, N Ogawa 1, T Shibagaki 1, M Kanisawa 1
PMCID: PMC1869251  PMID: 7717455

Abstract

To elucidate the pathogenesis of bronchioloalveolar lung carcinoma (BAC), we evaluated the lesion size, growth fraction, and p53 overexpression of atypical adenomatous hyperplasia (AAH) and early stage BAC. AAH was classified as showing low grade or high grade atypia. AAH-like carcinoma, presumably very early stage BAC, was distinguished from AAH in that it exhibited remarkable atypia suggestive of malignant potential and from overt BAC in that it lacked unequivocal malignant features, including invasive/destructive growth. The growth fraction was determined immunohistochemically in terms of the Ki-67 labeling index. The overexpression of p53 was evaluated by assessing the nuclear accumulation of immunoreactive p53 protein. Both the lesion size and the growth fraction increased from low grade AAH, to high grade AAH, to AAH-like carcinoma, and to overt adenocarcinoma. The overexpression of p53 in AAH-like carcinoma was similar to that in overt adenocarcinoma and was more frequent than that in AAH. Our findings indicate that AAH, AAH-like carcinoma, and overt BAC represent different categories, although the cellular events occurring in these lesions presumably represent a continuous spectrum of the changes that are reflected in the cytomorphology and lesion size. The findings here suggest that AAH and AAH-like carcinomas constitute a population of heterogeneous lesions representing different steps toward overt BAC.

Full text

PDF
876

Images in this article

878Figure 1
on p.878
879Figure 2
on p.879
880Figure 3
on p.880
880Figure 4
on p.880
881Figure 5
on p.881
881Figure 6
on p.881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsky S. H., Cameron R., Osann K. E., Tomita D., Holmes E. C. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer. 1994 Feb 15;73(4):1163–1170. doi: 10.1002/1097-0142(19940215)73:4<1163::aid-cncr2820730407>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  2. Bennett W. P., Colby T. V., Travis W. D., Borkowski A., Jones R. T., Lane D. P., Metcalf R. A., Samet J. M., Takeshima Y., Gu J. R. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res. 1993 Oct 15;53(20):4817–4822. [PubMed] [Google Scholar]
  3. Brambilla E., Gazzeri S., Moro D., Caron de Fromentel C., Gouyer V., Jacrot M., Brambilla C. Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol. 1993 Jul;143(1):199–210. [PMC free article] [PubMed] [Google Scholar]
  4. Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu. 1988;23(Pt 2):361–394. [PubMed] [Google Scholar]
  5. Fontanini G., Pingitore R., Bigini D., Vignati S., Pepe S., Ruggiero A., Macchiarini P. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol. 1992 Dec;141(6):1285–1290. [PMC free article] [PubMed] [Google Scholar]
  6. Gatter K. C., Dunnill M. S., Gerdes J., Stein H., Mason D. Y. New approach to assessing lung tumours in man. J Clin Pathol. 1986 Jun;39(6):590–593. doi: 10.1136/jcp.39.6.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  8. Harris C. C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993 Oct 28;329(18):1318–1327. doi: 10.1056/NEJM199310283291807. [DOI] [PubMed] [Google Scholar]
  9. Hirano T., Franzén B., Kato H., Ebihara Y., Auer G. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol. 1994 Feb;144(2):296–302. [PMC free article] [PubMed] [Google Scholar]
  10. Hiyoshi H., Matsuno Y., Kato H., Shimosato Y., Hirohashi S. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res. 1992 Jan;83(1):101–106. doi: 10.1111/j.1349-7006.1992.tb02358.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iggo R., Gatter K., Bartek J., Lane D., Harris A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 1990 Mar 24;335(8691):675–679. doi: 10.1016/0140-6736(90)90801-b. [DOI] [PubMed] [Google Scholar]
  12. Kerns B. J., Jordan P. A., Faerman L. L., Berchuck A., Bast R. C., Jr, Layfield L. J. Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol. 1994 Feb;101(2):192–197. doi: 10.1093/ajcp/101.2.192. [DOI] [PubMed] [Google Scholar]
  13. Kishimoto Y., Murakami Y., Shiraishi M., Hayashi K., Sekiya T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res. 1992 Sep 1;52(17):4799–4804. [PubMed] [Google Scholar]
  14. Kitagawa M. Autopsy study of lung cancer with special reference to scar cancer. Acta Pathol Jpn. 1965 May;15(2):199–222. [PubMed] [Google Scholar]
  15. Kodama T., Biyajima S., Watanabe S., Shimosato Y. Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. Am J Clin Pathol. 1986 Feb;85(2):146–151. doi: 10.1093/ajcp/85.2.146. [DOI] [PubMed] [Google Scholar]
  16. Li Z. H., Zheng J., Weiss L. M., Shibata D. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol. 1994 Feb;144(2):303–309. [PMC free article] [PubMed] [Google Scholar]
  17. MEYER E. C., LIEBOW A. A. RELATIONSHIP OF INTERSTITIAL PNEUMONIA HONEYCOMBING AND ATYPICAL EPITHELIAL PROLIFERATION TO CANCER OF THE LUNG. Cancer. 1965 Mar;18:322–351. doi: 10.1002/1097-0142(196503)18:3<322::aid-cncr2820180310>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  18. Miller R. R. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990 Oct;14(10):904–912. doi: 10.1097/00000478-199010000-00002. [DOI] [PubMed] [Google Scholar]
  19. Miller R. R., Nelems B., Evans K. G., Müller N. L., Ostrow D. N. Glandular neoplasia of the lung. A proposed analogy to colonic tumors. Cancer. 1988 Mar 1;61(5):1009–1014. doi: 10.1002/1097-0142(19880301)61:5<1009::aid-cncr2820610525>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  20. Mori M., Chiba R., Takahashi T. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis. Cancer. 1993 Oct 15;72(8):2331–2340. doi: 10.1002/1097-0142(19931015)72:8<2331::aid-cncr2820720808>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  21. Nakanishi K. Alveolar epithelial hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med. 1990 Apr;114(4):363–368. [PubMed] [Google Scholar]
  22. Nakayama H., Noguchi M., Tsuchiya R., Kodama T., Shimosato Y. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod Pathol. 1990 May;3(3):314–320. [PubMed] [Google Scholar]
  23. Nuorva K., Soini Y., Kamel D., Autio-Harmainen H., Risteli L., Risteli J., Vähäkangas K., Päkkö P. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol. 1993 Mar;142(3):725–732. [PMC free article] [PubMed] [Google Scholar]
  24. Ohshima S., Shimizu Y., Takahama M. Detection of c-Ki-ras gene mutation in paraffin sections of adenocarcinoma and atypical bronchioloalveolar cell hyperplasia of human lung. Virchows Arch. 1994;424(2):129–134. doi: 10.1007/BF00193491. [DOI] [PubMed] [Google Scholar]
  25. Porter P. L., Gown A. M., Kramp S. G., Coltrera M. D. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol. 1992 Jan;140(1):145–153. [PMC free article] [PubMed] [Google Scholar]
  26. RAEBURN C., SPENCER H. A study of the origin and development of lung cancer. Thorax. 1953 Mar;8(1):1–10. doi: 10.1136/thx.8.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schwarting R. Little missed markers and Ki-67. Lab Invest. 1993 Jun;68(6):597–599. [PubMed] [Google Scholar]
  28. Shimosato Y., Suzuki A., Hashimoto T., Nishiwaki Y., Kodama T., Yoneyama T., Kameya T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980 Aug;4(4):365–373. doi: 10.1097/00000478-198008000-00005. [DOI] [PubMed] [Google Scholar]
  29. Simony J., Pujol J. L., Radal M., Ursule E., Michel F. B., Pujol H. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res. 1990 Jul 15;50(14):4382–4387. [PubMed] [Google Scholar]
  30. Soomro I. N., Whimster W. F. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol. 1990 Nov;162(3):217–222. doi: 10.1002/path.1711620307. [DOI] [PubMed] [Google Scholar]
  31. Sozzi G., Miozzo M., Donghi R., Pilotti S., Cariani C. T., Pastorino U., Della Porta G., Pierotti M. A. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 1992 Nov 1;52(21):6079–6082. [PubMed] [Google Scholar]
  32. Sundaresan V., Ganly P., Hasleton P., Rudd R., Sinha G., Bleehen N. M., Rabbitts P. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 1992 Oct;7(10):1989–1997. [PubMed] [Google Scholar]
  33. Weidner N., Moore D. H., 2nd, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol. 1994 Apr;25(4):337–342. doi: 10.1016/0046-8177(94)90140-6. [DOI] [PubMed] [Google Scholar]
  34. Weng S., Tsuchiya E., Satoh Y., Kitagawa T., Nakagawa K., Sugano H. Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo-alveolar carcinoma. Histopathology. 1990 Jan;16(1):101–103. doi: 10.1111/j.1365-2559.1990.tb01073.x. [DOI] [PubMed] [Google Scholar]
  35. Westra W. H., Offerhaus G. J., Goodman S. N., Slebos R. J., Polak M., Baas I. O., Rodenhuis S., Hruban R. H. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol. 1993 Mar;17(3):213–220. doi: 10.1097/00000478-199303000-00001. [DOI] [PubMed] [Google Scholar]
  36. YOKOO H., SUCKOW E. E. Peripheral lung cancers arising in scars. Cancer. 1961 Nov-Dec;14:1205–1215. doi: 10.1002/1097-0142(196111/12)14:6<1205::aid-cncr2820140610>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  37. van den Berg F. M., Baas I. O., Polak M. M., Offerhaus G. J. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol. 1993 Feb;142(2):381–385. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES